Neurogene Inc. (NGNE) vs REGENXBIO Inc. (RGNX)
A side-by-side comparison of Neurogene Inc. and REGENXBIO Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NGNE
Neurogene Inc.
$25.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RGNX
REGENXBIO Inc.
$7.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NGNE vs RGNX
growth of $100 · dividends reinvested · last 10yNGNE -90.2% (-20.8%/yr)RGNX -44.8% (-5.8%/yr)RGNX compounded faster over this window
Log scale — wide-divergence pair
NGNE RGNX
NGNE vs RGNX: by the numbers
- •NGNE is the larger company ($402M vs $385M market cap).
- •Both run net losses; NGNE's is the smaller (0.00% vs -112.58% net margin).
Metrics side by side
Valuation
| Metric | NGNE | RGNX |
|---|---|---|
| P/S ratio | N/A | 2.21 |
| P/B ratio | 1.85 | 5.37 |
Profitability
| Metric | NGNE | RGNX |
|---|---|---|
| Gross margin | 0.00% | 88.09% |
| Operating margin | 0.00% | -94.08% |
| Net margin | 0.00% | -112.58% |
| ROE | -51.17% | -273.72% |
| ROIC | -54.45% | -54.00% |
Growth (annualized)
| Metric | NGNE | RGNX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 1.59% |
| Total return CAGR (5Y) | -27.73% | -24.15% |
Frequently asked
- How have NGNE and RGNX total returns compared?
- Over the past 10 years, NGNE delivered -21.02% and RGNX delivered -6.47% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.